MedPath

The Effect of Extracorporeal Shock Wave Therapy on Spasticity

Not Applicable
Completed
Conditions
Spasticity
Interventions
Device: Shock wave
Registration Number
NCT02221011
Lead Sponsor
Tri-Service General Hospital
Brief Summary

The effect of traditional treatment for spasticity is barely satisfactory. The shock wave has been used to treat the spasticity with expressively response and the effect could persist for 1-3 months in different studies. However most sutdies lack the sham or control group. The purpose of this study was to assess the effect of shock wave for spasticity in wrist and hand.

Detailed Description

The patients with spasticity for at least 6 months were randomized for 3 groups. Group I: patients receive one session of shock wave per week for 3 weeks; Group II: patients receive only one session of shock wave; Group III: patients receive the sham shock wave per week for 3 weeks. The outcome measurements include Modified Asthow scale, passive range of motion, Disability Assessment Scale and Fugl-Meyer Assessment Scale (hand function and wrist control).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

Age between 20-80 year-old Spasticity measured as Modified Asthow Scale more than 1+ point and persist at least 6 months Clear consciousness No receive Phenol injection or Botulinum toxin in past 6 months

Exclusion Criteria

Cancer Joint contracture Coagulopathy Pregnancy Pacemaker Inflammation status

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Shock wave (one time)Shock waveE-SWT, Elettronica Pagani, Italy 3.5 bars 1500 beats in FCU, FCR 3 bars 4000 beats diffuse in intrinsic muscle Only one dose
Sham shock waveShock waveE-SWT, Elettronica Pagani, Italy Sham without energy, 1500 beats in FCU, FCR and 4000 beats diffuse in intrinsic muscle
shock wave (three times)Shock waveE-SWT, Elettronica Pagani, Italy 3.5 bars 1500 beats in FCU, FCR 3 bars 4000 beats diffuse in intrinsic muscle Once a week for 3 weeks
Primary Outcome Measures
NameTimeMethod
Change from baseline of spasticity on 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment.Pre-treatment, 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment.

Using the modyfied Ashworth Scale to measure the spasticity before treatment and multiple time frame after treatment.

Secondary Outcome Measures
NameTimeMethod
Change from baseline of disability on 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment.Pre-treatment, 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment.

Using the Disability Assessment Scale to measure the disabilty scale before treatment and multiple time frame after treatment.

Change from baseline of range of motion on 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment.Pre-treatment, 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment.

Using the digital goniometer to measure the passive range of motion before treatment and multiple time frame after treatment.

Change from baseline of pain on 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment.Pre-treatment, 1st, 2nd, 4th, 8th, 12th and 16th weeks after treatment.

Using the Visual analog scale (VAS) to measure the pain from spasticity scale before treatment and multiple time frame after treatment.

Trial Locations

Locations (1)

Tri-Service General Hospital National Defense Medical Center

🇨🇳

Taipei, Neihu, Taiwan

© Copyright 2025. All Rights Reserved by MedPath